Ignite Creation Date:
2024-05-06 @ 5:55 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05476224
Status:
COMPLETED
Last Update Posted:
2023-10-02
First Post:
2022-07-25
Brief Title:
Qualitative and Functional Investigation of Lipids in Patients With SARS-CoV2 Infection - In Search of Atherogenic Sequelae
Sponsor:
Centre Hospitalier Universitaire Dijon
Organization:
Centre Hospitalier Universitaire Dijon
Study Overview
Official Title:
Qualitative and Functional Investigation of Lipids in Patients With SARS-CoV2 Infection - In Search of Atherogenic Sequelae
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COVI-LIPI-D
Brief Summary:
Currently the world is facing a SARS-CoV2 coronavirus epidemic which is responsible for COVID-19 In France this virus has already infected several million people and is responsible for the death of more than 127000
Infection is associated with a higher number of cardiovascular events myocardial infarction stroke cardiac arrhythmia thrombosis in the short and medium term after infection The long-term complications of this infection are not yet known and are the subject of research in France and in the world
In order to investigate the possible long term sequelae of this virus infection this research aims to evaluate the potential cholesterol abnormalities caused by COVID-19 which could play a significant role in the increase of cardiovascular risk in affected patients
A total of 180 analysable participants will be recruited in this study They will be divided into four groups of participants that will be compared to one another
30 participants who were infected with SARS-CoV2 with no or few signs and did not require hospitalization
30 participants who were infected with SARS-CoV2 and whose severity of illness required hospitalization in a COVID unit
30 participants who were infected with SARS-CoV2 and required intensive care hospitalization due to severity of illness
90 participants who were not infected with SARS-CoV2
For each participant the study will last approximately 1 hour the time to fill out the consent forms to answer a few questions about their current medical history and finally to take a blood sample for lipid measurements
Infection is associated with a higher number of cardiovascular events myocardial infarction stroke cardiac arrhythmia thrombosis in the short and medium term after infection The long-term complications of this infection are not yet known and are the subject of research in France and in the world
In order to investigate the possible long term sequelae of this virus infection this research aims to evaluate the potential cholesterol abnormalities caused by COVID-19 which could play a significant role in the increase of cardiovascular risk in affected patients
A total of 180 analysable participants will be recruited in this study They will be divided into four groups of participants that will be compared to one another
30 participants who were infected with SARS-CoV2 with no or few signs and did not require hospitalization
30 participants who were infected with SARS-CoV2 and whose severity of illness required hospitalization in a COVID unit
30 participants who were infected with SARS-CoV2 and required intensive care hospitalization due to severity of illness
90 participants who were not infected with SARS-CoV2
For each participant the study will last approximately 1 hour the time to fill out the consent forms to answer a few questions about their current medical history and finally to take a blood sample for lipid measurements
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None